Impact of Glucagon-like Peptide-1 Receptor Agonists on Metabolic Health in Liver Transplant Recipients
GLP-1RA therapy is safe after LT and is well tolerated. Aside from glycemic control, metabolic benefits of GLP-1RA included weight loss and lower prevalence of steatosis in LT recipients. The study findings provide much-needed safety data for GLP-1RA in LT patients and foundational data to design prospective trials to evaluate metabolic benefits of GLP-1RA.
Authors
- Mohammad Shadab Siddiqui (ORCID: https://orcid.org/0000-0001-7392-7489)
- Taylor Sprague (ORCID: https://orcid.org/0000-0002-7609-2306)
- Idris Yakubu (ORCID: https://orcid.org/0000-0002-7871-3479)
- Vasco M. Pontinha (ORCID: https://orcid.org/0000-0003-3333-1482)
- Sara Sterling (ORCID: https://orcid.org/0000-0003-1921-7798)
- Michael LaPorte
- Joseph Spengler
- Randolph S. Marks
- Perry Taylor
- Kavish Rohit Patidar (ORCID: https://orcid.org/0000-0003-3633-382X)
- Vaishali Patel (ORCID: https://orcid.org/0000-0002-2890-9457)
- A. Iaria (ORCID: https://orcid.org/0009-0004-3020-911X)
- A.M.S. Brown (ORCID: https://orcid.org/0000-0001-8750-4997)
- B. Agegnehu
Institutions
- Michael E. DeBakey VA Medical Center (US)
- Baylor College of Medicine (US)
- Virginia Commonwealth University (US)
Publication Details
- Journal
- Transplantation
- Published
- 2025-03-25
- DOI
- https://doi.org/10.1097/tp.0000000000005361
- Citations
- 7
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 9.06